Latest ROE for Healthstream: 5.94% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow5.94%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Healthstream (HSTM) currently reports a ROE of 5.94%. That is below the Healthcare sector average of 21.67%. Use the charts on this page to explore Healthstream's ROE history and peer comparisons.
Healthstream's ROE of 5.94% is lower than the Healthcare sector average of 21.67%. That is roughly 72.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Healthstream's current 5.94% should be judged against Healthcare norms (sector average: 21.67%) and against HSTM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 5.94%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Healthstream, and consider following HSTM for alerts when major investors trade the stock.
Healthstream is classified in the Healthcare sector. On ROE, it currently shows 5.94% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HSTM with unrelated industries.